Pear Therapeutics

Redefining medicine.

Pear Therapeutics discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Every day, we push the boundaries of technology to transform medicine. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions.

Company Information

Sector
Digital Therapeutics
First Investment
Series B
Year Partnered
2017
Status
Active
Location
Boston
CEO
Corey McCann